The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis

BACKGROUND: The role of adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) is not clear in early‐stage nonsmall‐cell lung cancer (NSCLC) patients. This meta‐analysis aims to compare the efficacy and safety of EGFR‐TKIs as adjuvant therapy with chemotherapy or placebo in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Thorac Cancer
Main Authors: Lin, Chutong, Hu, Fengling, Chu, Hongling, Ren, Peng, Ma, Shanwu, Wang, Jingdi, Bai, Jie, Han, Xuan, Ma, Shaohua
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons Australia, Ltd 2021
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017245/
https://ncbi.nlm.nih.gov/pubmed/33660941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13874
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki